Correction

The article ‘Atopic dermatitis: new and emerging treatments’ by Dr Laxmi Iyengar and Dr Lena Ly, which was published in the March 2025 issue of Medicine Today (pages 49­-55), contains an error. Conjunctivitis was listed as an adverse effect of nemolizumab. This is incorrect; conjunctivitis is not an adverse effect of nemolizumab. Commonly reported adverse effects of nemolizumab are nasopharyngitis and upper respiratory tract infections. This has been corrected on page 55. We apologise for this oversight and any confusion it may have caused. The online version and full­text PDF of this article are correct at: https://medicinetoday.com.au/mt/2025/march/regular­-series/atopic-dermatitis-new-­and-emerging-­treatments